AI Bias Analysis
4 models · Takes ~15 seconds
The 5th Circuit’s ruling on mifepristone “is bad for health care access, and it’s also bad for innovation,” writes Grace E. Colón.
Source
Stat News
Opens original article in a new tab
France's medicines regulator has fined Novo Nordisk and Eli Lilly over their weight loss ad campaigns.
(MedPage Today) -- Kids who had acute kidney injury (AKI) during a hospitalization often experienced lasting health consequences, a meta-analysis showed. Pooled cumulative incidences were 17% for chronic kidney disease (CKD), 6% for mortality...
(MedPage Today) -- When a 24-year-old woman took a dietary supplement called "raiz de tejocote," she encountered some dangerous and unpleasant side effects. On arrival to the emergency department, she was experiencing confusion, nausea, vomiting...
(MedPage Today) -- In "Beyond Diagnosis: Vaccines," Cleveland Clinic infectious disease specialist Donald Dumford III, MD, and host John Mangels continue their conversations on communicating effectively and empathetically with patients around vaccination...
